feed,title,long_url,short_url
MarketWatch,Immunovant stock loses half its value after pausing dosing in trial of thyroid eye disease treatment,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/_2FBpnYkYwo/story.aspx,https://on.mktw.net/3aveYbL
MarketWatch,Durect stock soars 34% after it gets FDA approval for surgical pain treatment,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/1eoRsiLLSyg/story.aspx,https://on.mktw.net/36A0ru2
